Streetbeat News

NAUT

Nautilus Biotechnology, Inc.

https://www.nautilus.bio

Industry

Biotechnology

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Open

2.49

Mkt cap

289M

Volume

114K

High

2.49

P/E Ratio

-4.11

52-wk high

3.46

Low

2.30

Div yield

N/A

52-wk low

2.19

Nautilus Biotechnology has entered into a sales agreement with Cowen for the sale of common stock, aiming for aggregate sales proceeds of up to $125 million. This move is part of Nautilus Biotechnology's efforts to raise capital.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:28 pm

Nautilus Biotechnology (NASDAQ:NAUT) reported Q4 2023 GAAP EPS of $(0.14), surpassing the $(0.15) estimate by 6.67%. However, this represents a 27.27% increase in losses compared to $(0.11) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:10 pm

The article lists companies scheduled to report their earnings on February 28, 2024, including their expected earnings per share and revenue. It covers a wide range of sectors and provides a comprehensive overview of the financial performance expectations for these companies.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 11:24 am

Nautilus Biotechnology has filed a lawsuit in US District Court against SomaLogic and the California Institute of Technology, seeking a declaratory judgment that it does not infringe on any claims of US Patent No. 7,842,793, which is related to DNA origami structures.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 9:23 pm

In Friday's after-market session, several healthcare stocks experienced significant movements. Forte Biosciences (FBRX) saw an 11.8% increase, while Telesis Bio (TBIO) rose by 10.81%. AcelRx Pharmaceuticals (ACRX), DermTech (DMTK), Renalytix (RNLX), and IN8bio (INAB) also gained. Conversely, Nautilus Biotechnology (NAUT), OpGen (OPGN), Bone Biologics (BBLG), ProSomnus (OSA), Kintara Therapeutics (KTRA), and Altamira Therapeutics (CYTO) declined. The movements were attributed to recent earnings reports and trading volumes.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 9:31 pm

Nautilus Biotechnology reported Q3 losses of $(0.13) per share, beating the analyst consensus estimate of $(0.17) by 23.53 percent. However, this is an 18.18 percent increase in losses compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 11:17 am

During Thursday's after-market session, several healthcare stocks experienced significant movement. Novo Integrated Sciences (NVOS), OpGen (OPGN), Intelligent Bio Solutions (INBS), Brainstorm Cell (BCLI), BioSig Technologies (BSGM), and Tenax Therapeutics (TENX) saw gains, while Tonix Pharmaceuticals (TNXP), Bionomics (BNOX), Coeptis Therapeutics (COEP), Athersys (ATHX), Nautilus Biotechnology (NAUT), and Avalo Therapeutics (AVTX) experienced losses.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 9:31 pm

Despite a general downturn in the U.S. stock market, several stocks recorded gains on Monday. Canopy Growth Corporation, ESS Tech, Sea Limited, Williams-Sonoma, Nikola Corporation, MultiPlan Corporation, AMC Entertainment Holdings, Diversified Healthcare Trust, Nautilus Biotechnology, RLX Technology, and Soho House & Co Inc. all saw increases. Notably, Williams-Sonoma's rise followed Green Equity Investors IX, L.P. increasing its stake in the company to 5%, and ESS Tech's gain came after a strategic collaboration with Honeywell International.

Portfolio Pulse from Lisa Levin

September 25, 2023 | 2:45 pm

Several US stocks traded down, with Farfetch Ltd, Faraday Future Intelligent Electric Inc, TriSalus Life Sciences Inc, Beneficient, Pharvaris NV, VinFast Auto, Genelux Corp, Nautilus Biotechnology Inc, VNET Group Inc, Jiayin Group Inc, and TMC The Metals Company Inc all recording losses. Factors contributing to the decline include soft quarterly results, weak guidance, exit from the beauty category, delivery of first EV for the ultra-luxury market, concerns over further interest rate hikes by the Federal Reserve, and second-quarter results.

Portfolio Pulse from Lisa Levin

August 18, 2023 | 3:46 pm

US stocks traded down with the Nasdaq Composite falling more than 101 points. Deere & Company reported better than expected Q3 results and raised its fiscal 2023 guidance, but its stock declined 3.9% due to concerns over the end of the agricultural equipment demand boom. Other stocks mentioned include Nautilus Biotechnology, Meta Data Ltd, Hawaiian Electric Industries, TriSalus Life Sciences, Jiayin Group, and TMC The Metals Company.

Portfolio Pulse from Lisa Levin

August 18, 2023 | 3:08 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.